Natera, Inc. announced that on December 10, 2024, the District Court for the Middle District of North Carolina granted its request to include an additional patent in its ongoing lawsuit against NeoGenomics, Inc. This expands the scope of Natera's patent infringement claims.
Natera's amended complaint now asserts infringement of both U.S. Patent No. 11,319,596 and U.S. Patent No. 11,530,454 by the new version of NeoGenomics’ RaDaR® test. This action follows previous injunctions against NeoGenomics’ prior RaDaR® test versions.
The inclusion of an additional patent strengthens Natera's legal position in its efforts to seek full remedies against NeoGenomics’ current RaDaR® test offering, including injunctive relief. This move underscores Natera's commitment to defending its proprietary technology.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.